Professional Documents
Culture Documents
Organization Study of Biocon LTD
Organization Study of Biocon LTD
Organization Study of Biocon LTD
Antioxidants
Cardiovascular agents
Digestive aid enzymes
Haemostatic agents
Immunosuppressants
Nuetraceuticals
Actiblok am tablet
McKensy’s 7S framework
1. STRENGTH: 2. WEAKNESS:
Strong R&D Department Decline in net cash
flow
Innovation
Diseconomies to
Online growth scale
Strong management team Weak, damaged
brand
3. OPPORTUNITIES: 4. THREATS:
Acquisitions Competition
Emerging markets and Cheaper technology
expansion of product External
Should focus on the changes( government,
Product and service policies, taxes etc)
growth Product substitution
Takeover
FINANCIALS
Current Ratio
Year Mar-16 Mar-17 Mar-18 Mar-19 Mar-20
Current
Ratio
2.75 3.37 2.47 2.46 2.86
Debt equity
ratio 0.040 0.034 0.023 0.019 0.006
LIQUID RATIO
Liquid
Ratio 2.16 2.61 1.80 1.66 2.13
PROPRIETARY RATIO
Proprietary
Ratio 1.269 1.285 1.189 1.228 1.210
Learning experience
I learnt about overall functioning and working of an
organization
Understanding the financial concepts and analyzing the
various ratios and aspects
Learned about the SWOT Analysis of the organization
By studying Mckensy’s framework of the company I was
able to analyse various variables influencing the company
and its role which has an impact on the company.